"Frankly eye-popping!" That's what renowned ALS researcher, Dr. Bob Brown of @UMassChan, said about #NurOwn biomarker results when speaking with other researchers at the ALS/MND Conference on December 10, 2021. Now we know why. Dr. Brown is the senior author on the NurOwn biomarker data published in @MuscleAndNerve. This graphic is an excerpt of some of the most promising CSF biomarkers detailed in the paper's "Supporting Information." Check out those p-values! Treatment with NurOwn led to "significant changes in 64% of the 45 analyzed biomarkers," spanning critical pathways involved in #ALS pathology: 🔹#neuroinflammation 🔹#neuroprotection 🔹#neurodegeneration ⬇️ SUPPORTING INFORMATION: onlinelibrary.wiley.com/action/downloa… #neurotwitter #neurology #neurologist #MND #neuromuscular #neurodegenerativedisease #motorneurondisease #neuron #inflammation #EndALS $BCLI